Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Scope Health recalls Optase Dry Eye Intense Drops (Glycerin 0.2%)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Optase Dry Eye Intense Drops (Glycerin 0.2%)
Company
Scope Health
Where it was sold

Nationwide within the United States

Nationwide

About this recall
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.